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Abstract. Anal fissure (AF) is a common proctologic disease and health problem, with potential for chronicity, causing the 
patient a debilitating suffering. The pathogenesis, in most of the cases consists in a vicious circle of pain-internal anal 
sphincter (IAS) spasm-decrease blood irrigation of mucosa-delay of healing. Treatment should aim to break this mechanism 
by cutting or relaxing the IAS and restoring adequate blood flow to promote healing. If anal stretch is becoming history, 
surgical sphincterotomy has the highest rate of healing and the least percentage of recurrence, but incontinence for flatus 
and stool may occur so “medical or “chemical” sphincterotomy using calcium channel blockers (CCB), nitric oxide donors, 
botulinum toxin injection are used with success rates from 50% to over 90%, also in combination with other conservative 
measures like warm sitz baths, stool softeners, high fiber and more liquid daily ingestion. All of those therapeutic measures 
are also stated in current guidelines. The question we tried to answer in this paper is for how long we can prolong the 
conservative, non-operative treatment in AF. Based upon literature research and our personal experience we may state that 
the earlier institution of medical specific treatment (CCB, nitric oxide donors, botulinum toxin) has more chances to heal the 
patient and avoid surgery. Success is also dependent on the good communication with the patient, detailed explanation of 
the purpose of the treatment, how to assess himself the evolution, and employ botulinum toxin earlier if patient is less 
compliant to topic treatment. Conservative non-operative management should be pushed as long as it is correctly applied 
and progression is made both from subjective and objective point of view and patient is compliant and content. 




The definition of an anal fissure according to the Man-
ual of Coloproctology, second edition is a painful tear in 
the epithelial lining of anoderma anterior or posterior, 
distal to the dentate line [1].  
The etiology is considered to be multifactorial, in-
cluding passage of hard stools, forceful and bulky 
defecation, diarrhea, trauma and other causes.  
From the objective point of view, we encounter 2 
types of anal fissures in our practice, as every other 
proctologist does. The recent fissures, usually less than 
2 weeks, which are linear in shape, sharp, clean edges, 
bleeding during the examination that we may call acute 
anal fissures (AAF).  
The other aspect is an anal fissure, triangular in shape, 
with apex at the dentate line, base at the anal verge, a 
“sentinel pile” on the outside, a hypertrophic papilla at 
the apex, edges may be sclerous, the base of the fissure 
may exhibit fibers of the internal sphincter, without any 
objective sign of granulation tissue. In the old books, this 
was the classical description of an anal fissure, nowadays 
we consider this a chronic fissure (CAF). 
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Pathogenesis of the Chronic Anal Fissure 
The pathogenesis of the CAF is surely a complex one, 
there is no single mechanism involved.  
The most consistent findings in anal fissures are the 
hypertonicity of the internal sphincter with an elevated 
resting tone. This is an objective sign that we note 
immediately when we try to examine the patient by 
digital tact, that is mostly impossible, requiring seda-
tion, local anesthesia by topic of injection, loco-regional 
or general anesthesia to complete the proctologic exami-
nation. Manometric studies of the resting anal tone sup-
port this objective finding [2]. 
Internal sphincter spasm is generated by the pres-
ence of the fissure, deep enough to expose the sensitive 
nerve endings and it is reflex and it is decreasing the 
blood flow that crosses it to reach anoderma, contrib-
uting to a delayed or no healing progression. This has 
been demonstrated in several studies assessing the blood 
perfusion using Doppler laser flowmetry [3, 4]. 
In most of the cases this chronic aspects of AF are 
located at the posterior and anterior commissures, only 
10% of the patients having fissures at the anterior mid-
line and in 1% both commissures being involved [5]. 
Anterior location is more frequent in women [6]. There 
is a postulate that fissures occurring on other places than 
anterior and posterior commissures should raise the 
suspicion of other diseases like Crohn disease, sexually 
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transmitted disease or even AIDS [7]. Explanation of 
this predilection may come in the majority of cases, 
from the anatomy, blood supply coming from inferior 
rectal arteries, on both sides, crossing the internal anal 
sphincter to reach anal anoderma, do not have any or 
minimal contact in the posterior commissure in 85% of 
cases. This fact was demonstrated by Klosterhafen et al 
in. a post-mortem angiographic study [8]. 
A personal observation is that cicatrization may be 
delayed also in patients suffering from chronic diseases 
as diabetes mellitus or renal insufficiency, due to the 
alteration of small blood vessels as a result of a systemic 
disease. All of those features suggest that the anal fis-
sure behaves like a chronic ischemic wound, due to a 
vicious circle of “pain - IAS spasm - decreased blood 
flow - no healing - pain”. Some studies found consisting 
evidence for small blood vessels alterations similar to a 
vasculopathy. Maria et al. identified in the peripheral 
blood of patients with chronic anal fissures circulating 
antibodies against intimal endothelial cells and deposits 
of antigen-antibody complexes in the small branches of 
the rectal arteries [9]. 
Treatment 
Not all acute anal fissures go into this vicious circle 
leading to a non-healing, ischemic wound. Normally, a 
wound in this area should heal spontaneously like any 
other wound in the human body, in a period of maxi-
mum 2 weeks. A part of them may indeed do so, as in 
the anamnesis of the patients, they report episodes of 
constipation, with pain after one strenuous, difficult 
defecation, after an episode of constipation, bleeding on 
paper, pain that reappears after several stools with mi-
nor bleeding, symptoms typically related to an anal 
fissure, but they gradually resolve and, when seen in 
consultation, the examination reveals normal anoderma. 
Some of the patients performed by themselves sitz 
baths, take stool softeners or laxatives, eat more fibers 
and drink more liquids to soften the stools, a fact that 
reduces the pain after defecation and improves symp-
toms. Some of them consult their pharmacist or family 
doctor, in the best case, and are advised to use oint-
ments, suppositories, jelly containing substances that 
promote local contact anesthesia, have anti-inflamma-
tory, siccative effect, and promote cicatrization, made 
either from natural plants or synthetic. These products 
are plenty on the market, and are advertised for hemor-
rhoids and/or anal fissures, consisting in fact in a purely 
symptomatic treatment. This treatment is considered as 
conservative one and is used by many specialists in 
proctology as a first line therapy and is also included in 
guidelines. Treatment of CAF anal fissure should not 
aim to the wound itself but to the breaking of this vi-
cious circle by any means, by addressing the internal 
anal sphincter spasm and improving blood flow. 
From its first description in 1829 by Recamier, we 
have the first therapeutic measure indicated as anal 
stretching, a technique that will weaken the thin internal 
anal sphincter by overstretch, but without any control in 
preventing damages to the external anal sphincter, there-
fore it is considered historic. 
The most successful treatment of the AF was surgi-
cal sphincterotomy, initially performed in the AF’s bed, 
cutting only through the fibers of the anal sphincter that 
are visible, or going up to the dentate line, excising 
wound edges, papilla and sentinel pile a so called fis-
surectomy, that will rejuvenate the wound and help 
healing.  
This operation was successful in almost all cases but 
left a deformity of a keyhole appearance or a groove 
responsible for a period of time of minor leakage of 
liquid drops of stools or staining the underwear. In some 
patients this could be permanent, in others may be pre-
sent for a determined period of time.  
To avoid this, recently a lateral sphincterotomy is in-
dicated, involving the distal part of the internal sphinc-
ter. An anterior internal sphincterotomy is prohibited by 
the fact that external anal sphincter is weaker in this 
region. The success of the surgical sphincterotomy is 
related to the amount of internal sphincter that is cut. A 
complete sphincterotomy, up to the dentate line will be 
mostly effective in healing almost all fissures but may 
increase the percentage of the incontinence symptoms. 
Risk of incontinence may be as high as 10%, especially 
for flatus [10, 11]. A postal survey of patients operated 
for anal fissure revealed a higher rate of incontinence: 
28.7% for stool and 31.5% for gas. Risk for inconti-
nence may increase over the years because of the weak-
ening of the anal sphincter with age [12]. If a lateral 
sphincterotomy is performed, a part of 25% up to 50% 
of sphincter maybe cut with good results in healing and 
risk of incontinence [1] the recurrence maybe higher or 
healing incomplete in worst cases, but it can be ex-
tended by a second intervention.  
Another possibility is to tailor the sphincterotomy 
only for the fibers of internal sphincter seen in the fis-
sure bed. Both techniques are credited with lower rate of 
incontinence.  
The way of doing it: open or closed sphincterotomy 
is a matter of choice depending upon the expertise of the 
proctologist, we prefer to lay it open to avoid formation 
of abscesses, the patient will be taught to performed 
regular sitz baths, perform self anal dilation with oint-
ments that include local anesthetics and even local 
antibiotics, but this is low grade recommendation, based 
upon personal expertise and not on high grade evidence. 
Medical Treatment 
The necessity of avoiding those side-effects pushed 
specialist in seeking a “Medical Sphincterotomy” or a 
“reversible sphincterotomy” or a “chemical sphincterot-
omy” in decreasing the internal sphincter tone by oral, 
topic medication, or botox injections. 
Calcium channel blockers (CCB) Oral Nifedipine, 
Nifedipine gel 0.20.5%, Diltiazem cream 4%, were 
employed with success in treatment of AF based on the 
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effect of relaxing the smooth muscle, inducing vasodila-
tation and reducing anal spasm. The side effect is hypo-
tension and headache. Topic application has more local 
direct effect and less systemic side-effects [13, 14] 
Nitric oxide donors. Nitric oxide is a neurotransmit-
ter that induces smooth muscle relaxation and therefore, 
internal sphincter relaxation. The mostly employed are 
glyceryl-trinitrate (GTN) and nitro glyceryn (NTG). 
GTN is used in concentrations of 0.2% to 0.4%. Alt-
hough demonstrated effective in treating AF [15], con-
trary to what we might have expected higher concentra-
tions do not offer higher rates of healing [16]. NTG is 
used in concentrations from 0.10.6%. Healing takes 
place usually after 6-8 weeks but sometimes it requires 
12 weeks to heal. Side-effects, more often encountered 
if the dosage is increased, are headaches, making a part 
of the patients non-compliant to the treatment. The phe-
nomenon of tachyphilaxia is also possible making 
necessary to increase dosage [17]. 
Botulinum toxin (Botox) 
The role is to induce a local paralysis of the IAS for a 
period of 34 months, that should be enough for a 
complete healing. The effects are reversible and so are 
any incontinence symptoms during the treatment. Indi-
cated for AF is the botulinum toxin type A [18]. The 
dosage found to be effective is 2025 units injected in 
the anal sphincter. Studies regarding the dosage showed 
a surprising evidence of an efficiency in healing and 
incontinence non influenced by the dosage, formulation 
and type of toxin. Also the site and number of injections 
per session didn’t influence the healing rate [19]. Lower 
doses of botox reduce the risk of incontinence and 
recurrence in the long term. The optimum injection site 
could not be determined [20]. For example, in our 
experience, we use to inject a total amount of 25 units 
(toxine type A), 12.5% on each side of the CAF.  
Comparison between Different Treatments  
A systematic review and meta-analysis of all published 
treatments for anal fissure that have been studied in 
randomized controlled trials was performed by Nelson et 
al. relatively recent in 2017. The conclusions are very 
clear supporting calcium channel blockers over GTN, 
with less risk for headache as side effects, a feature im-
portant for long-term treatments. The rate of healing is 
lesser that of lateral surgical sphincterotomy that is cred-
ited with a rather lower rate of incontinence of 3.44.4%. 
This is probably due to performing a distal internal 
sphincterotomy rather than a complete one. Open LIS and 
closed LIS were equal in regards of efficiency [21]. 
Botox injections have a risk of anal incontinence, but 
fewer side-effects compared to nitric oxide donors [22]. 
The Sequence of Treatment  
Indicated in the Guidelines  
The 2014 American College of Gastroenterology clini-
cal guideline on the management of benign anorectal 
disorders made the following recommendations for anal 
fissure [11]:  
Acute anal fissure  Providers should use nonoperative 
treatments (e.g., sitz baths, psyllium fiber, and bulking 
agents) as the first step in therapy (strong recommendation, 
moderate-quality evidence) 
Chronic anal fissure  Providers should treat chronic 
anal fissure with topical pharmacologic agents (eg, calcium 
channel blockers or nitrates) (strong recommendation, 
moderate-quality evidence)  
Chronic anal fissure  Providers should refer pa-
tients who do not respond to conservative or pharmaco-
logic treatment for local injections of botulinum toxin 
(strong recommendation, low-quality evidence) or inter-
nal anal sphincterotomy (strong recommendation, high-
quality evidence) [23]. 
The question to be answered is for how long should 
we keep the patient on medical on conservative (non-
surgical) treatment before referring him to surgery? 
If it is an acute anal fissure the dietary changes, sitz 
baths, local symptomatic ointments heal the fissure in 
the majority of cases [24]. Rates of healing may be up to 
5080%. It a fissure has a chronic aspect, the response 
to such dietary and habits changes is rather low. In those 
cases this will remain as an “adjuvant” to the medical 
treatment [25]. We should not prolong this kind of treat-
ment beyond 23 weeks at maximum, because this 
simply mostly symptomatic treatment, because after this 
period the AF is entered probably in the vicious circle 
mechanism that doesn’t allow further healing. 
In a study performed by Sileri et al, in which the pa-
tients were submitted gradually to medical treatment first, 
botox injection and as a last resource IS, we may find 
some orientating results. Beside dietary adjustment, sitz 
baths, initially, the patients with CAF were submitted to 
NTG 0.2% twice a day, applied to the fissure and to the 
internal sphincter for a period of 8 weeks with a rate of 
healing of 54%. If the patient was still symptomatic after 
8 weeks, Botox injections were proposed or prolongation 
of treatment with NTG. After 12 weeks the rate of 
healing was 64% for NTG. Rate of healing after Botox 
was 84%. Patient showing an incomplete healing were 
submitted to either another injection of Botox or surgical 
sphincterotomy. LIS had a cure rate of 98.7% with no 
definitive incontinence on long-term follow up [26]. 
Personal observation come from a series of 567 pa-
tients seen in the last 4 years in consultation in our 
clinic as outpatient, their observation files were re-
trieved and data within reexamined and analyzed. There 
was a slight male predominance of 307/267 (1,15 x 
higher). Most of the patients were in the 3050 years of 
age - 252 (44.44%), 20% under 30 years, and 35% over 
50 years of age. So, nearly 80% of patients were over 30 
years old. Co-morbidities of arterial hypertension were 
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met in 69 patients, diabetes mellitus in 31 and irritable 
bowel syndrome in 56.  
Beside the basic recommendations as stool softeners, 
sitz baths, dietary fibers, laxatives etc. the patients were 
treated with topical medical ointments to relax the anal 
sphincter and were advised to apply it at lest 4 times per 
day and seen regularly every 2 weeks. 207 patients 
healed after 2 weeks (36.5%), 147 after 1 month (26%), 
90 (16%) between 412 weeks and 72 (12.7%) patients 
needed treatment for longer than 12 weeks. 10 patients 
were treated by botox and registered complete healing 
and 25 patients (4.4%) required an internal sphincterot-
omy for complete healing that was performed in the 
fissure bed involving only the sphincter up to the apex 
of the fissure. 
We have noticed a direct relationship between the 
duration of fissure symptoms and the period of healing.  
The most important thing during the period of treat-
ment is good communication with the patient, detailed 
explanations of different methods of treatment, ad-
vantages and disadvantages, risk of side-effects, inconti-
nence and adapt to the symptoms and psychology of 
each patient. The patient should be instructed to con-
tinue performing sitz baths, taking fibers, drinking 
plenty liquids, using laxatives, glycerin suppositories, 
small enemas to unblock the stools, and apply rigor-
ously and very correctly the topical treatment. Gener-
ally, even in patients with the worst symptoms there is a 
clear consistent improvement after 5-6 days in intensity 
and duration of pain. The patient should be given as an 
orientation for the progression of treatment to follow 
those 2 aspects and report them at each visit. Also video 
documentation should be used to monitor healing and 
motivate the patient (Figs. 1 and 2). 
Even after the healing the patient should remain on a 
rich fiber diet, with plenty of liquids, avoid constipation by 
glycerin suppositories, small enemas or soft laxatives to 
avoid hard stools. In our experience, constipation was the 
main cause for the recurrence of the fissure. The medical 
treatments as NTG, CCB are useful and cheaper but 
necessitate administration in at least two times/daily, best 
45 times for a period of time from 2 weeks to 12 weeks, 
the median is 6-8 weeks. We noticed a linear relationship 
between the period of anal fissure and the time of healing, 
the longer the history of fissure, more time is taking to 
complete healing. The disadvantage is the necessity of 
multiple applications, necessitating some minimal 
conditions of privacy and hygiene during the day, or in the 
working place, some minor degree of tachyphylaxis. The 
patient should be seen every two weeks to be sure that the 
applications is correct, the diet is correct and adjust 
treatments by changing topical treatments 
Botox is a very good option and could be recom-
mended after 68 weeks of topic treatment. The disad-
vantage is the cost. Otherwise, the botox therapy could be 
very well proposed to the patients from the first place. In 
patients that are not compliant from any reason for topical 
treatment this could be recommended from the first place 
The choice between medical treatments of botox, the 
sequence, the decision to inject botox should always 
comply with the patient. Remember that we treat pa-
tients and not disease. Detailed discussion with the pa-
tient, good communication, details about habits, diet, 
style of life, job at least should be obtained, the ad-
vantage s and disadvantages of every type of treatment 
should be exposed and the decision taken after consider-
ing at least all those factors and the choice of patient.  
In conclusion, the conservative, non-operative treat-
ment should be pushed as much as possible, and surgery 
avoided as much as possible, as long as the pain and 
compliance of the patient otherwise passage to surgery 
is the most reliable and sure thing to heal. 
The conservative treatment involves a great deal of 
work and communication with the patient, but it may be 
rewarding at the end, and even if a recurrence take place 
this is due to mainly to patient lack of adherence to the 
principles of diet. Of course, each recurrence may be 
treated with success again by medical non-surgical ther-
apy and again the decision should be taken together 
with the patient and if necessary surgery will be per-
formed when compliance of the patient is obtained. 
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Fig. 2 Posterior chronic anal fissure with fibroses in the 
fissure’s bed, granulation tissue on the edges, under 
medical treatment  
 
Fig. 1 Anterior CAF with clean edges, some granulation 
tissue visible in the fissure bed, triangular shape  
aspect in evolution under medical treatment  
Conservative Treatment for Anal Fissure - For How Long?  Review of the Literature and Personal Experience 11 
References
1. Espin E. Anal fissure. In: Herold A, Lehur P-A, Matzel KE, 
O’Connel PR, eds. Manual of coloproctology. 2nd edition. Berlin 
Heidelberg: Springer Verlag; 2017. p. 4759. 
2. Lund JN, Scholefield JH. Aetiology and treatment of anal fissure. 
Br J Surg 1996; 83:13351344. 
3. Schouten WR, Briel JW, et al. Relationship between anal pressure 
and anodermal blood flow: the vascular pathogenesis of anal 
fissure. Dis Colon Rectum 1994; 37:664669.  
4. Gibbons CP, Read NW. Anal hypertonia in fissures: Cause or 
effect? Br J Surg 1986; 58:96. 
5. Kodner IJ, Fry RD, Fleshman J W, Birnbaum EH, Read TE. Colon, 
Rectum and Anus. In: Seymour I. Schwartz et al, eds. Principles of 
Surgery. 7th ed. Mc Grow-Hill; 1999. p.12651382.  
6. Jenkins JT, Urie A, Molloy RG. Anterior anal fissures areassociated  
with  occult  sphincter  injury  and  abnormalsphincter function. 
Colorectal Dis 2008; 10(3):280–285.  
7. Zaghyian KN, Fleschner P. Anal fissure. Clin Colon Rectal Surg 
2011; 24:22–30. 
8. Klosterhalfen B, Vogel P, et al. Typography of the inferior rectal 
artery: a possible cause of chronic primary fissure. Dis Colon 
Rectum 1989; 32:4352.  
9. Maria G, Brissinda D, et al. Identification of anti-endothelial cell 
antibodies (EACA) in patients with chronic anal fissures. Surgery 
1999; 126:535540. 
10. Nelson R. Non surgical therapy for anal fissure. Cochrane Database 
Syst Rev 2006;(4):CD003431.  
11. Nelson R. Operative procedures for fissure in ano. Cochrane 
Database Syst Rev 2005;(2):CD002199. 
12. Jameson JS, ChiaYW, Kamm MA, Speakman CT, ChyeYH, Henry 
MM. Effect of age, sex and parity on anorectal function. Br J Surg 
1994; 81:16891692. 
13. Jonas M, Neal KR, Abercrombie JF, Scholefield JH. Arandomized 
trial of oral vs. topical diltiazem for chronic analfissures. Dis Colon 
Rectum 2001; 44(8):1074–1107.  
14. Perrotti P, Bove A, Antropoli C, et al. Topical nifedipinewith 
lidocaine ointment vs. active control for treatment ofchronic anal 
fissure: results of a prospective, randomized,double-blind study. Dis 
Colon Rectum 2002; 45(11):1468–1475.  
15. Nelson R. Non surgical therapy for anal fissure. Cochrane Database 
Syst Rev 2006; (4):CD00343 
16. Scholefield JH, Bock JU, Marla B, et al. A dose findingstudy with 
0.1%, 0.2%, and 0.4% glyceryl trinitrate ointmentin patients with 
chronic anal fissures. Gut 2003; 52(2):264–269.  
17. Lund JN, Scholefield JH. A prospective, randomized double-blind 
placebo controlled trial of glyceryl trinitrate in anal fissure. Lancet 
1997; 349:1114. 
18. Maria G, Casetta E, et al. A comparison of botulinum toxin and 
saline injection for treatment of chronic anal fissure. N Engl J Med 
1998; 338:217220.  
19. Bobkiewicz A, Francuzik W, Krokowicz L, Studniarek A, 
Ledwosiński W, Paszkowski J, Drews M, Banasiewicz T. 
Botulinum Toxin Injection for Treatment of Chronic Anal Fissure: 
Is There Any Dose-Dependent Efficiency? A Meta-Analysis. 
World J Surg 2016; 40(12):30643072.  
20. Lin JX, Krishna S, Su'a B, Hill AG. Dosing of Botulinum Toxin for 
Treatment of Chronic Anal Fissure: A Systematic Review and 
Meta-Analysis. Dis Colon Rectum 2016; 59(9):886894. 
21. Nelson RL, Manuel D, Gumienny C, Spencer B, Patel K, Schmitt 
K, Castillo D, Bravo A, Yeboah-Sampong A. A systematic review 
and meta-analysis of the treatment of anal fissure. Tech Coloproctol 
2017; 21(8):605625. 
22. Sahebally SM, Meshkat B, Walsh SR, Beddy D. Botulinum toxin 
injection vs topical nitrates for chronic anal fissure: an updated 
systematic review and meta-analysis of randomized controlled 
trials. Colorectal Dis 2018; 20(1):615. 
23. Wald A, Bharucha AE, Cosman BC, Whitehead WE. ACG clinical 
guideline: management of benign anorectal disorders. Am J 
Gastroenterol 2014; 109(8):11411157;  
24. Beck DE, Timmcke AE. Pruritus ani and fissure-in-ano. In: Beck 
DE, ed. Handbook of Colorectal Surgery. 2nd ed. New York: 
Marcel Dekker; 2003. p. 367. 
25. Lund JN, Scholefield JH. Aetiology and treatment of anal fissure. 
Br J Surg 1996; 83:13351344.  
26. Sileri P, Stolfi VM, Franceschilli L.  Grande M,  di Giorgio A, 
D’Ugo S, Attina G, D’Eletto M, Gaspari AL. Conservative and 
surgical treatment of chronic anal fissures: prospective long-term 
results. J Gastrointest Surg 2010; 14:773–780. 
 
